To check Oneindia News on your Mobile
go to:   http://m.oneindia.in/news/
  •  

NE states seek trade point at Pangasu Pass in Mizoram

Aizawl, Feb 20 (UNI) The NE states have urged Union Commerce Ministry to set up third trade point at Pangsau Pass in Mizoram to boost up the volume of trade with Myanmar.

Commerce ministry officials here today said India and Myanmar had set a target of achieving USD one billion in 2006-07 and only USD 650 million trade has so far been done in this fiscal.

Identifying the declining border trade through Moreh in Manipur, the officials said it was due to lack of memorandum of understanding between the designated banks on both sides, restriction on export of plant and plant materials as well as on items in barter trade.

Under the Indo-Myanmar bilateral border trade agreement of 1994, trade is being carried out through designated border points of Moreh in Manipur and Zowkhathar in Mizoram.

NE states opined the view to set up another trading point at Pangsau Pass to improve trade figures, which will help the economy of NE India as well as Myanmar, officials said.

Indo-Myanmar trade has grown nearly eight-fold since 1980, which reached USD 557 million in 2004-05 from a level of USD 12.4 million in 1980-81.

Strategically, increasing border trade with Myanmar will help India to reach out to ASEAN members as well as pursuing Look East Policy and control China's influence on Myanmar.

UNI

Shayam Sunder to be Sahebganj DC

Ranchi, Feb 20 (UNI) Jharkhand tourism additional secretary Shayam Sunder Prasad has been appointed as Deputy Commissioner of Sahebganj, an official release said here today. Mr Prasad would take over the charge in place of Junnu Kisku, who was on leave. Mr Kisku would join at the personnel and administrative reform department of the state government after completion of his leave, the release said. UNI.....

Biocon, Bentley receive approval from DGCI for Nasulin

Bangalore, Feb 20 (UNI) India's largest Insulin producer, Biocon Limited, today announced that its licensing partner, Bentley Pharmaceuticals Inc, a speciality pharma company, has received approval from the Drug Controller General of India (DCGI) to proceed with Phase II clinical evaluation of Nasulin in Type II diabetics. This approval followed the completion of Bentley's pharmacokinetic clinical studies of Nasulin studies in India. The Phase II study would be initiated in March 2007 and was expected to be completed before the.....

Biocon' US partner bags DGCI nod for diabetes drug

New Delhi, Feb 20 (UNI) Biocon Ltd today said its United States-based licensing partner Bentley Pharmaceuticals has been approved by the Drug Controller General of India (DCGI) to proceed with a phase II clinical evaluation of insulin drug, Nasulin. Nasulin is Bentley's intranasal insulin product for type II diabetes formed by utilising its proprietary delivery technology CPE-215. As per the licensing agreement, the company is responsible for developing and marketing Nasulin in India and select territories. The company.....
User Comments
[ Post Comments ]
Be the first to comment on this article.
Oneindia  Oneindia Login